LAKESHA ALEXIS: Open Payments
NPI 1205436425 · MARIETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,009 in 44 payments from 16 companies in 2025. Trend: 2023 $1,682 · 2024 $1,477 · 2025 $1,009
Food & beverage: $1,009
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 10 | $179 |
| Astellas Pharma US Inc | 3 | $170 |
| Novartis Pharmaceuticals Corporation | 8 | $153 |
| PFIZER INC. | 5 | $110 |
| AstraZeneca Pharmaceuticals LP | 4 | $86 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $57 |
| Boston Scientific Corporation | 1 | $37 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33 |
| United Therapeutics Corporation | 1 | $32 |
| Imperative Care, Inc | 1 | $32 |
Products named: Veozah, LEQVIO, WINREVAIR, VYNDAQEL, VERQUVO, WAINUA, LifeVest, WATCHMAN Access System.
Industry payments across GA — which companies pay providers there.
